Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|September 13, 2025
Geographic Variation in Persistence of Oral Anticoagulant Treatment Among Patients with Non-Valvular Atrial Fibrillation in the United StatesBrett D Atwater, Risho Singh, Ali Bonakdar, et al.
Current Medical Research and Opinion|November 6, 2025
Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixabanDominick Latremouille-Viau, Aolin Wang, Dong Cheng, et al.
Journal of Managed Care & Specialty Pharmacy|January 26, 2024
Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolismDionne M Hines, Riddhi Doshi, Vamshi Ruthwik Anupindi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 3, 2025
Geographic and Racial Variation in Oral Anticoagulant (OAC) Treatment Among Commercially Insured Patients with Non-valvular Atrial Fibrillation (NVAF) in the United StatesBrett D Atwater, Risho Singh, Shashi Parmar, et al.
Journal of Clinical Medicine|June 27, 2024
Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE)James C Coons, Vamshi Ruthwik Anupindi, Riddhi Doshi, et al.
Pageof 1